Nicotine Patch as an Analgesic Adjuvant After Surgery
This study has been completed.
Sponsor:
Columbia University
Information provided by:
Columbia University
ClinicalTrials.gov Identifier:
NCT00440830
First received: February 26, 2007
Last updated: October 29, 2010
Last verified: October 2010
- Full Text View
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Purpose
Detailed Description:
Effect of nicotine patch as an adjutant for acute pain after surgery.
Condition | Intervention | Phase |
---|---|---|
Pain |
Drug: nicotine patch Drug: placebo |
Phase 4 |
Study Type: | Interventional |
Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor) Primary Purpose: Treatment |
Official Title: | Study to Determine Whether the Use of a Nicotine Patch During the Day of Surgery Improves Postoperative Pain and Reduces Opioid Requirement. |
Resource links provided by NLM:
MedlinePlus related topics:
Nausea and Vomiting
Drug Information available for:
Nicotine polacrilex
U.S. FDA Resources
Further study details as provided by Columbia University:
Primary Outcome Measures:
- Postoperative Pain Score One Hour After Surgery [ Time Frame: 1 hour after surgery ] [ Designated as safety issue: No ]Postoperative pain reported after the first hour using a standard numerical rating scale (NRS) with 0=no pain and 10=worst pain imaginable.
- Postoperative Pain Score Five Days After Surgery [ Time Frame: 5 days ] [ Designated as safety issue: No ]Postoperative pain reported after five days using a standard numerical rating scale (NRS) with 0=no pain and 10=worst pain imaginable.
Secondary Outcome Measures:
- Nausea Assessment by Patient [ Time Frame: 1 hour after surgery ] [ Designated as safety issue: No ]Nausea scale range: 0=none and 10=the worst, ordinal.
- Sedation [ Time Frame: 1 hour after surgery ] [ Designated as safety issue: No ]Observer's Assessment of Alertness/Sedation Scale was used to report sedation.
- Pain Medication Used [ Time Frame: 5 days ] [ Designated as safety issue: No ]Pain medication used after surgery in morphine equivalents
- Systolic Blood Pressure [ Time Frame: 1 hour after surgery ] [ Designated as safety issue: No ]Systolic blood pressure reported in Millimeters of Mercury (mmHg)
- Diastolic Blood Pressure [ Time Frame: 1 hour after surgery ] [ Designated as safety issue: No ]Diastolic blood pressure reported in Millimeters of Mercury (mmHg)
- Heart Rate [ Time Frame: 1 hour after surgery ] [ Designated as safety issue: No ]Heart rate reported in Beats per minute (BPM)
Enrollment: | 68 |
Study Start Date: | December 2005 |
Study Completion Date: | December 2008 |
Primary Completion Date: | December 2008 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
Experimental: Smokers-nicotine
Smokers who were treated with nicotine
|
Drug: nicotine patch
nicotine patch (0,5,10 or 15mg/day) applied to smokers
Other Name: nicotrol
|
Experimental: Nonsmokers-nicotine
Nonsmokers who were treated with nicotine
|
Drug: nicotine patch
nicotine patch (0,5,10,or 15mg/day) applied to nonsmokers
Other Name: nicotrol
|
Placebo Comparator: Smokers-placebo
Smokers who were treated with placebo
|
Drug: placebo
placebo patch applied to smokers
|
Placebo Comparator: Nonsmokers-placebo
Nonsmokers who were treated with placebo
|
Drug: placebo
placebo patch applied to nonsmokers
|
Detailed Description:
This is a dose finding trial for nicotine patches as analgesics. Doses used are 5mg/ 10mg/ 15mg or placebo. Primary outcome variable is reported pain score (VAS), secondary is morphine PCA utilization, nausea, sedation, and hemodynamic changes.
Eligibility
Ages Eligible for Study: | 18 Years to 60 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Adult ASA 1-2
Exclusion Criteria:
- Cardiovascular disease
- Former smoker
- Pregnant
- Nursing
- Asthma
Contacts and Locations
More Information
Publications:
Keywords provided by Columbia University:
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on September 30, 2012
Publications:
Responsible Party: | Pamela Flood, Columbia University |
ClinicalTrials.gov Identifier: | NCT00440830 History of Changes |
Other Study ID Numbers: | AAAB5945 |
Study First Received: | February 26, 2007 |
Results First Received: | October 1, 2010 |
Last Updated: | October 29, 2010 |
Health Authority: | United States: Food and Drug Administration |
Keywords provided by Columbia University:
acute pain nicotine nausea sedation |
Additional relevant MeSH terms:
Nicotine Nicotine polacrilex Ganglionic Stimulants Autonomic Agents Peripheral Nervous System Agents Physiological Effects of Drugs Pharmacologic Actions Nicotinic Agonists |
Cholinergic Agonists Cholinergic Agents Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Central Nervous System Stimulants Central Nervous System Agents Therapeutic Uses |
ClinicalTrials.gov processed this record on September 30, 2012